FDA Drug recall D-0412-2018
Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51
- FDA Drug
- Class III
- terminated
- Published 2018-02-07
On 2018-02-07 the FDA classified a Class III recall of Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51 by Abbvie, citing defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0412-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-01-22 |
| Published | 2018-02-07 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Abbvie |
| Distribution | MS, OH |
Product
Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51
Reason
Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.
Identifiers
| ndc | 0074-4456-51 |
|---|---|
| code_info | Lot #: 1088856, Exp 6/20 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0412-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.